Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $22.2900 (0.59%) ($22.2900 - $22.2900) on Wed. Aug. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.99% (three month average) | RSI | 14 | Latest Price | $22.2900(0.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -1.6% a day on average for past five trading days. | Weekly Trend | TGTX declines -20.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.995% in a week (0% probabilities). VIXM(-46%) VXX(-39%) UUP(-19%) IGOV(-8%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.995% (StdDev 3.99%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.99(-131.36%) | Resistance Level | $31.25 | 5 Day Moving Average | $23.21(-3.96%) | 10 Day Moving Average | $26.09(-14.56%) | 20 Day Moving Average | $31.25(-28.67%) | To recent high | -44.9% | To recent low | 0.6% | Market Cap | $2.823b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |